Sorrento Therapeutics, Inc.·4

Nov 27, 7:48 PM ET

SHAH JAISIM 4

4 · Sorrento Therapeutics, Inc. · Filed Nov 27, 2018

Insider Transaction Report

Form 4
Period: 2018-11-26
SHAH JAISIM
Director
Transactions
  • Award

    Stock Options

    2018-11-26+35,00035,000 total
    Exercise: $3.57Exp: 2028-11-26Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date.

Documents

1 file
  • 4
    wf-form4_154336608310581.xmlPrimary

    FORM 4